MyTomorrows is expanding to the U.S. and bringing its recipe for patient access to clinical trial drugs
MyTomorrows has had its greatest success in Europe, but is looking forward to bringing its services to the U.S.
Dutch life science startup offers access to late-stage drugs for patients with few options
A Dutch life science startup is collaborating with biotechnology companies to make it easier for patients with advanced chronic conditions and unable to get into clinical trials to access potentially life-saving drugs before they are cleared by regulators. MyTomorrows positions itself as a patient-focused company and recently raised $2.2 million from friends and family to […]
presented by
Market Trends to Watch for Health Systems and Their Specialty Pharmacies
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.